MPH Health Care AG

XETRA 93M1.DE

MPH Health Care AG Price to Book Ratio (P/B) on January 14, 2025: 0.38

MPH Health Care AG Price to Book Ratio (P/B) is 0.38 on January 14, 2025, a 38.06% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • MPH Health Care AG 52-week high Price to Book Ratio (P/B) is 0.59 on June 04, 2024, which is 56.55% above the current Price to Book Ratio (P/B).
  • MPH Health Care AG 52-week low Price to Book Ratio (P/B) is 0.27 on January 16, 2024, which is -28.71% below the current Price to Book Ratio (P/B).
  • MPH Health Care AG average Price to Book Ratio (P/B) for the last 52 weeks is 0.39.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
XETRA: 93M1.DE

MPH Health Care AG

CEO Mr. Patrick Brenske
IPO Date May 16, 2011
Location Germany
Headquarters GrUenauer Strasse 5
Employees 2
Sector Health Care
Industries
Description

MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.

Similar companies

A1OS.DE

All for One Group SE

USD 61.63

-0.72%

MUX.DE

Mutares SE & Co. KGaA

USD 25.71

0.40%

M12.DE

M1 Kliniken AG

USD 15.97

3.61%

STO3.DE

Sto SE & Co. KGaA

USD 109.04

0.41%

StockViz Staff

January 15, 2025

Any question? Send us an email